Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: CDK4, . Treffer: 17
2022
Mayer, EL; Fesl, C; Hlauschek, D; Garcia-Estevez, L; Burstein, HJ; Zdenkowski, N; Wette, V; Miller, KD; Balic, M; Mayer, IA; Cameron, D; Winer, EP; Ponce, Lorenzo, JJ; Lake, D; Pristauz-Telsnigg, G; Haddad, TC; Shepherd, L; Iwata, H; Goetz, M; Cardoso, F; Traina, TA; Sabanathan, D; Breitenstein, U; Ackerl, K; Metzger, Filho, O; Zehetner, K; Solomon, K; El-Abed, S; Theall, KP; Lu, DR; Dueck, A; Gnant, M; DeMichele, A
Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03).
J Clin Oncol. 2022; JCO2101918
Doi: 10.1200/JCO.21.01918
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Suppan, C
ESMO 2021-my top three abstracts in breast cancer
MEMO-MAG EUR MED ONC. 2022;
Doi: 10.1007/s12254-022-00810-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Turkovic, L; Bockor, L; Ekpenyong, O; Silovski, T; Lovric, M; Crnkovic, S; Nigovic, B; Sertic, M
Development and Validation of a Novel LC-MS/MS Method for the Simultaneous Determination of Abemaciclib, Palbociclib, Ribociclib, Anastrozole, Letrozole, and Fulvestrant in Plasma Samples: A Prerequisite for Personalized Breast Cancer Treatment
PHARMACEUTICALS-BASE. 2022; 15(5): 614
Doi: 10.3390/ph15050614
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2021
Dandachi, N; Posch, F; Graf, R; Suppan, C; Klocker, EV; Müller, HD; Lindenmann, J; Terbuch, A; Heitzer, E; Balic, M
Longitudinal tumor fraction trajectories predict risk of progression in metastatic HR+ breast cancer patients undergoing CDK4/6 treatment.
Mol Oncol. 2021; 15(9):2390-2400
Doi: 10.1002/1878-0261.12870
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2020
Birnhuber, A; Egemnazarov, B; Biasin, V; Bonyadi Rad, E; Wygrecka, M; Olschewski, H; Kwapiszewska, G; Marsh, LM
CDK4/6 inhibition enhances pulmonary inflammatory infiltration in bleomycin-induced lung fibrosis.
Respir Res. 2020; 21(1):167-167
Doi: 10.1186/s12931-020-01433-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gajzer, DC; Fletcher, CD; Agaimy, A; Brcic, I; Khanlari, M; Rosenberg, AE
Primary gastrointestinal liposarcoma-a clinicopathological study of 8 cases of a rare entity.
Hum Pathol. 2019; 97:80-93
Doi: 10.1016/j.humpath.2019.12.004
Web of Science
PubMed
FullText
FullText_MUG
Koch, C; Kuske, A; Joosse, SA; Yigit, G; Sflomos, G; Thaler, S; Smit, DJ; Werner, S; Borgmann, K; Gärtner, S; Mossahebi Mohammadi, P; Battista, L; Cayrefourcq, L; Altmüller, J; Salinas-Riester, G; Raithatha, K; Zibat, A; Goy, Y; Ott, L; Bartkowiak, K; Tan, TZ; Zhou, Q; Speicher, MR; Müller, V; Gorges, TM; Jücker, M; Thiery, JP; Brisken, C; Riethdorf, S; Alix-Panabières, C; Pantel, K
Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity.
EMBO Mol Med. 2020; 12(9):e11908-e11908
Doi: 10.15252/emmm.201911908
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Müller, C; Wendt, J; Rauscher, S; Burgstaller-Muehlbacher, S; Sunder-Plassmann, R; Scheurecker, C; Richtig, E; Fae, I; Fischer, G; Pehamberger, H; Okamoto, I
Characterization of patients at high risk of melanoma in Austria.
BRIT J DERMATOL. 2016; 174(6): 1308-1317.
Doi: 10.1111/bjd.14407
Web of Science
PubMed
FullText
FullText_MUG
Ohtsuka, M; Ling, H; Ivan, C; Pichler, M; Matsushita, D; Goblirsch, M; Stiegelbauer, V; Shigeyasu, K; Zhang, X; Chen, M; Vidhu, F; Bartholomeusz, GA; Toiyama, Y; Kusunoki, M; Doki, Y; Mori, M; Song, S; Gunther, JR; Krishnan, S; Slaby, O; Goel, A; Ajani, JA; Radovich, M; Calin, GA
H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal Cancer.
EBioMedicine. 2016; 13(3):113-124
Doi: 10.1016/j.ebiom.2016.10.026
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Aoude, LG; Heitzer, E; Johansson, P; Gartside, M; Wadt, K; Pritchard, AL; Palmer, JM; Symmons, J; Gerdes, AM; Montgomery, GW; Martin, NG; Tomlinson, I; Kearsey, S; Hayward, NK
POLE mutations in families predisposed to cutaneous melanoma.
Fam Cancer. 2015; 14(4):621-628
Doi: 10.1007/s10689-015-9826-8
Web of Science
PubMed
FullText
FullText_MUG
2014
Bernhart, E; Damm, S; Heffeter, P; Wintersperger, A; Asslaber, M; Frank, S; Hammer, A; Strohmaier, H; DeVaney, T; Mrfka, M; Eder, H; Windpassinger, C; Ireson, CR; Mischel, PS; Berger, W; Sattler, W
Silencing of protein kinase D2 induces glioma cell senescence via p53-dependent and -independent pathways.
Neuro Oncol. 2014; 16(7):933-945
Doi: 10.1093/neuonc/not303
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fric, J; Lim, CX; Mertes, A; Lee, BT; Viganò, E; Chen, J; Zolezzi, F; Poidinger, M; Larbi, A; Strobl, H; Zelante, T; Ricciardi-Castagnoli, P
Calcium and calcineurin-NFAT signaling regulate granulocyte-monocyte progenitor cell cycle via Flt3-L.
Stem Cells. 2014; 32(12):3232-3244
Doi: 10.1002/stem.1813
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Kollmann, K; Heller, G; Schneckenleithner, C; Warsch, W; Scheicher, R; Ott, RG; Schäfer, M; Fajmann, S; Schlederer, M; Schiefer, AI; Reichart, U; Mayerhofer, M; Hoeller, C; Zöchbauer-Müller, S; Kerjaschki, D; Bock, C; Kenner, L; Hoefler, G; Freissmuth, M; Green, AR; Moriggl, R; Busslinger, M; Malumbres, M; Sexl, V
A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis.
Cancer Cell. 2013; 24(2):167-181
Doi: 10.1016/j.ccr.2013.07.012
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2012
Shirsath, NP; Manohar, SM; Joshi, KS
P276-00, a cyclin-dependent kinase inhibitor, modulates cell cycle and induces apoptosis in vitro and in vivo in mantle cell lymphoma cell lines.
Mol Cancer. 2012; 11:77-77
Doi: 10.1186/1476-4598-11-77
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2006
Fargnoli, MC; Argenziano, G; Zalaudek, I; Peris, K
High- and low-penetrance cutaneous melanoma susceptibility genes.
EXPERT REV ANTICANCER THER. 2006; 6: 657-670.
Doi: 10.1586/14737140.6.5.657
Web of Science
PubMed
FullText
FullText_MUG
1997
Kovar, H; Jug, G; Aryee, DN; Zoubek, A; Ambros, P; Gruber, B; Windhager, R; Gadner, H
Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors.
Oncogene. 1997; 15(18):2225-2232
Doi: 10.1038/sj.onc.1201397
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1995
Sill, H; Goldman, JM; Cross, NC
Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia.
Blood. 1995; 85(8):2013-2016
Doi: 10.1182/blood.V85.8.2013.bloodjournal8582013
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG